AKT1 and urinary bladder cancer: Furthermore, CD147 expression is associated with the response to chemotherapy for bladder cancer, and Misra et al. [43] demonstrated that CD147 enhances tumor growth and chemoresistance via the phosphatidylinositol 3-kinase (PI3K)/Akt pathway in a hyaluronan-dependent manner.